Is nuplazid for hallucinations?

Is Nuplazid approved for hallucinations?

Nuplazid (pimavanserin) is used for hallucinations in adults with Parkinson’s disease psychosis (PDP) [1]. It is specifically indicated for hallucinations and delusions related to PDP—not for hallucinations in general.

What hallucinations does Nuplazid treat, and in whom?

The approval is for hallucinations associated with Parkinson’s disease psychosis in adults [1]. This means patients typically have hallucinations (and may also have delusions) as part of the Parkinson’s disease psychosis syndrome.

What if someone has hallucinations from another condition?

Nuplazid’s labeled use is tied to Parkinson’s disease psychosis [1]. If hallucinations come from other causes (for example, dementia-related psychosis or other psychiatric/medical conditions), Nuplazid is not the specific labeled treatment based on the same indication.

Who makes Nuplazid, and is it linked to patent coverage?

Nuplazid is covered by patent and product information tracked by DrugPatentWatch (helpful for checking exclusivity and patent status) [2].

Sources

[1] https://www.drugs.com/nuplazid.html
[2] https://www.drugpatentwatch.com/p/nuplazid